BOF vs LFVN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals critical weaknesses in BOF's financial health, highlighted by a Piotroski F-Score of 0/9, indicating severe operational and financial distress. Despite a strong year-over-year revenue growth of 47.60% and a current ratio above 1.6, the company is deeply unprofitable with a profit margin of -49.75% and an alarming ROE of -168.18%. Valuation multiples like Price/Book of 7.18 and Price/Sales of 3.58 appear stretched given the lack of earnings, negative cash flow, and absence of a calculable Altman Z-Score, which raises concerns about solvency. While insider sentiment is moderately positive at 40/100, it does not offset the overwhelming financial instability and weak technical trend of 0/100.
LFVN exhibits severe financial deterioration, highlighted by a weak Piotroski F-Score of 3/9 and a completely bearish technical trend (0/100). While the Graham Number ($5.9) and low P/E (6.92) suggest a value opportunity, these are likely 'value traps' given the catastrophic collapse in fundamentals, including a -27.8% YoY revenue decline and a -89.5% drop in earnings. The company has failed to beat earnings estimates in the last four consecutive quarters, with an average surprise of -36.33%. Despite a strong balance sheet with low debt, the operational trajectory is unsustainable.
Compare Another Pair
Related Comparisons
BOF vs LFVN: Head-to-Head Comparison
This page compares BranchOut Food Inc. (BOF) and LifeVantage Corporation (LFVN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.